APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diclofenac Sodium Enteric-coated Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diclofenac Sodium Enteric-coated Tablets Market Outlook and Growth Opportunities 2026

26 December 2025209 pages

Choose your research edition.

Industry ResearchDiclofenac Sodium Enteric-coated Tablets Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Diclofenac Sodium Enteric-coated Tablets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Diclofenac Sodium Enteric-coated Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diclofenac Sodium Enteric-coated Tablets Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Diclofenac Sodium Enteric-coated Tablets Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Diclofenac Sodium Enteric-coated Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diclofenac Sodium Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diclofenac Sodium Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diclofenac Sodium Enteric-coated Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diclofenac Sodium Enteric-coated Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diclofenac Sodium Enteric-coated Tablets market include Changchun Changqing Pharmaceutical Group Co., Ltd., Changchun Changhong Pharmaceutical Co., Ltd., Xinxiang Changle Pharmaceutical Co., Ltd., Renhetang Pharmaceutical Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Jiangxi Jurentang Pharmaceutical Co., Ltd., Jilin Changheng Pharmaceutical Co., Ltd., Jilin Yinok Pharmaceutical Co., Ltd. and Jilin Guowen Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diclofenac Sodium Enteric-coated Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diclofenac Sodium Enteric-coated Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diclofenac Sodium Enteric-coated Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diclofenac Sodium Enteric-coated Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Diclofenac Sodium Enteric-coated Tablets Segment by Company

Changchun Changqing Pharmaceutical Group Co., Ltd.

Changchun Changhong Pharmaceutical Co., Ltd.

Xinxiang Changle Pharmaceutical Co., Ltd.

Renhetang Pharmaceutical Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Jiangxi Jurentang Pharmaceutical Co., Ltd.

Jilin Changheng Pharmaceutical Co., Ltd.

Jilin Yinok Pharmaceutical Co., Ltd.

Jilin Guowen Pharmaceutical Co., Ltd.

Jilin ASEAN Pharmaceutical Co., Ltd.

Huizhou Daya Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Henan Blueprint Pharmaceutical Co., Ltd.

Guangdong Rote Pharmaceutical Co., Ltd.

Guangdong South China Pharmaceutical Group Co., Ltd.

Guangdong Bangmin Pharmaceutical Factory Co., Ltd.

Ganmei (Guangdong) Pharmaceutical Co., Ltd.

Foshan Shouxin Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd.

Diclofenac Sodium Enteric-coated Tablets Segment by Type

25mg

50mg

Diclofenac Sodium Enteric-coated Tablets Segment by Application

Hospital

Clinic

Other

Diclofenac Sodium Enteric-coated Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diclofenac Sodium Enteric-coated Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diclofenac Sodium Enteric-coated Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diclofenac Sodium Enteric-coated Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Diclofenac Sodium Enteric-coated Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diclofenac Sodium Enteric-coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diclofenac Sodium Enteric-coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diclofenac Sodium Enteric-coated Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diclofenac Sodium Enteric-coated Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diclofenac Sodium Enteric-coated Tablets industry.

Chapter 3: Detailed analysis of Diclofenac Sodium Enteric-coated Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diclofenac Sodium Enteric-coated Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diclofenac Sodium Enteric-coated Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diclofenac Sodium Enteric-coated Tablets Industry Trends Table 2. Diclofenac Sodium Enteric-coated Tablets Industry Drivers Table 3. Diclofenac Sodium Enteric-coated Tablets Industry Opportunities and Challenges Table 4. Diclofenac Sodium Enteric-coated Tablets Industry Restraints Table 5. Global Diclofenac Sodium Enteric-coated Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diclofenac Sodium Enteric-coated Tablets Revenue Share by Company (2021-2026) Table 7. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Diclofenac Sodium Enteric-coated Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Diclofenac Sodium Enteric-coated Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diclofenac Sodium Enteric-coated Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Diclofenac Sodium Enteric-coated Tablets Company, Product Type & Application Table 13. Global Diclofenac Sodium Enteric-coated Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diclofenac Sodium Enteric-coated Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 25mg Table 18. Significant Companies of 50mg Table 19. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type (2021-2026) Table 28. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application (2021-2026) Table 41. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application (2027-2032) Table 42. Global Diclofenac Sodium Enteric-coated Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Diclofenac Sodium Enteric-coated Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Diclofenac Sodium Enteric-coated Tablets Sales Market Share by Region (2021-2026) Table 45. Global Diclofenac Sodium Enteric-coated Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Diclofenac Sodium Enteric-coated Tablets Sales Market Share by Region (2027-2032) Table 47. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Region (2021-2026) Table 50. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Region (2027-2032) Table 52. Global Diclofenac Sodium Enteric-coated Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Diclofenac Sodium Enteric-coated Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Diclofenac Sodium Enteric-coated Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Diclofenac Sodium Enteric-coated Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Diclofenac Sodium Enteric-coated Tablets Sales Market Share by Country (2021-2026) Table 58. Global Diclofenac Sodium Enteric-coated Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Diclofenac Sodium Enteric-coated Tablets Sales Market Share by Country (2027-2032) Table 60. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Market Share by Country (2027-2032) Table 64. Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information Table 65. Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview Table 66. Changchun Changqing Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Changchun Changqing Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 68. Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Development Table 69. Changchun Changhong Pharmaceutical Co., Ltd. Company Information Table 70. Changchun Changhong Pharmaceutical Co., Ltd. Business Overview Table 71. Changchun Changhong Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Changchun Changhong Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 73. Changchun Changhong Pharmaceutical Co., Ltd. Recent Development Table 74. Xinxiang Changle Pharmaceutical Co., Ltd. Company Information Table 75. Xinxiang Changle Pharmaceutical Co., Ltd. Business Overview Table 76. Xinxiang Changle Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Xinxiang Changle Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 78. Xinxiang Changle Pharmaceutical Co., Ltd. Recent Development Table 79. Renhetang Pharmaceutical Co., Ltd. Company Information Table 80. Renhetang Pharmaceutical Co., Ltd. Business Overview Table 81. Renhetang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Renhetang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 83. Renhetang Pharmaceutical Co., Ltd. Recent Development Table 84. Livzon Group Livzon Pharmaceutical Factory Company Information Table 85. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 86. Livzon Group Livzon Pharmaceutical Factory Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Livzon Group Livzon Pharmaceutical Factory Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 88. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 89. Jiangxi Jurentang Pharmaceutical Co., Ltd. Company Information Table 90. Jiangxi Jurentang Pharmaceutical Co., Ltd. Business Overview Table 91. Jiangxi Jurentang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Jiangxi Jurentang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 93. Jiangxi Jurentang Pharmaceutical Co., Ltd. Recent Development Table 94. Jilin Changheng Pharmaceutical Co., Ltd. Company Information Table 95. Jilin Changheng Pharmaceutical Co., Ltd. Business Overview Table 96. Jilin Changheng Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jilin Changheng Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 98. Jilin Changheng Pharmaceutical Co., Ltd. Recent Development Table 99. Jilin Yinok Pharmaceutical Co., Ltd. Company Information Table 100. Jilin Yinok Pharmaceutical Co., Ltd. Business Overview Table 101. Jilin Yinok Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jilin Yinok Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 103. Jilin Yinok Pharmaceutical Co., Ltd. Recent Development Table 104. Jilin Guowen Pharmaceutical Co., Ltd. Company Information Table 105. Jilin Guowen Pharmaceutical Co., Ltd. Business Overview Table 106. Jilin Guowen Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jilin Guowen Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 108. Jilin Guowen Pharmaceutical Co., Ltd. Recent Development Table 109. Jilin ASEAN Pharmaceutical Co., Ltd. Company Information Table 110. Jilin ASEAN Pharmaceutical Co., Ltd. Business Overview Table 111. Jilin ASEAN Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Jilin ASEAN Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 113. Jilin ASEAN Pharmaceutical Co., Ltd. Recent Development Table 114. Huizhou Daya Pharmaceutical Co., Ltd. Company Information Table 115. Huizhou Daya Pharmaceutical Co., Ltd. Business Overview Table 116. Huizhou Daya Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Huizhou Daya Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 118. Huizhou Daya Pharmaceutical Co., Ltd. Recent Development Table 119. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 120. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 121. Henan Baiquan Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Henan Baiquan Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 123. Henan Baiquan Pharmaceutical Co., Ltd. Recent Development Table 124. Henan Blueprint Pharmaceutical Co., Ltd. Company Information Table 125. Henan Blueprint Pharmaceutical Co., Ltd. Business Overview Table 126. Henan Blueprint Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Henan Blueprint Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 128. Henan Blueprint Pharmaceutical Co., Ltd. Recent Development Table 129. Guangdong Rote Pharmaceutical Co., Ltd. Company Information Table 130. Guangdong Rote Pharmaceutical Co., Ltd. Business Overview Table 131. Guangdong Rote Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Guangdong Rote Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 133. Guangdong Rote Pharmaceutical Co., Ltd. Recent Development Table 134. Guangdong South China Pharmaceutical Group Co., Ltd. Company Information Table 135. Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview Table 136. Guangdong South China Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Guangdong South China Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 138. Guangdong South China Pharmaceutical Group Co., Ltd. Recent Development Table 139. Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Company Information Table 140. Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Business Overview Table 141. Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 143. Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Recent Development Table 144. Ganmei (Guangdong) Pharmaceutical Co., Ltd. Company Information Table 145. Ganmei (Guangdong) Pharmaceutical Co., Ltd. Business Overview Table 146. Ganmei (Guangdong) Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Ganmei (Guangdong) Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 148. Ganmei (Guangdong) Pharmaceutical Co., Ltd. Recent Development Table 149. Foshan Shouxin Pharmaceutical Co., Ltd. Company Information Table 150. Foshan Shouxin Pharmaceutical Co., Ltd. Business Overview Table 151. Foshan Shouxin Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Foshan Shouxin Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 153. Foshan Shouxin Pharmaceutical Co., Ltd. Recent Development Table 154. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 155. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 156. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 158. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 159. Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Company Information Table 160. Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Business Overview Table 161. Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio Table 163. Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Diclofenac Sodium Enteric-coated Tablets Distributors List Table 167. Diclofenac Sodium Enteric-coated Tablets Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Diclofenac Sodium Enteric-coated Tablets Product Image Figure 2. Global Diclofenac Sodium Enteric-coated Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diclofenac Sodium Enteric-coated Tablets Sales (2021-2032) & (K Units) Figure 5. Global Diclofenac Sodium Enteric-coated Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Diclofenac Sodium Enteric-coated Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 25mg Image Figure 10. 50mg Image Figure 11. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Diclofenac Sodium Enteric-coated Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Diclofenac Sodium Enteric-coated Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Diclofenac Sodium Enteric-coated Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Diclofenac Sodium Enteric-coated Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changchun Changqing Pharmaceutical Group Co., Ltd.
  • Changchun Changhong Pharmaceutical Co., Ltd.
  • Xinxiang Changle Pharmaceutical Co., Ltd.
  • Renhetang Pharmaceutical Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Jiangxi Jurentang Pharmaceutical Co., Ltd.
  • Jilin Changheng Pharmaceutical Co., Ltd.
  • Jilin Yinok Pharmaceutical Co., Ltd.
  • Jilin Guowen Pharmaceutical Co., Ltd.
  • Jilin ASEAN Pharmaceutical Co., Ltd.
  • Huizhou Daya Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Henan Blueprint Pharmaceutical Co., Ltd.
  • Guangdong Rote Pharmaceutical Co., Ltd.
  • Guangdong South China Pharmaceutical Group Co., Ltd.
  • Guangdong Bangmin Pharmaceutical Factory Co., Ltd.
  • Ganmei (Guangdong) Pharmaceutical Co., Ltd.
  • Foshan Shouxin Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diclofenac Sodium Enteric-coated Tablets Market Dynamics
  1. 2.1 Diclofenac Sodium Enteric-coated Tablets Industry Trends
  2. 2.2 Diclofenac Sodium Enteric-coated Tablets Industry Drivers
  3. 2.3 Diclofenac Sodium Enteric-coated Tablets Industry Opportunities and Challenges
  4. 2.4 Diclofenac Sodium Enteric-coated Tablets Industry Restraints
3 Diclofenac Sodium Enteric-coated Tablets Market by Company
  1. 3.1 Global Diclofenac Sodium Enteric-coated Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Diclofenac Sodium Enteric-coated Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Diclofenac Sodium Enteric-coated Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Diclofenac Sodium Enteric-coated Tablets Company Ranking (2024-2026)
  6. 3.6 Global Diclofenac Sodium Enteric-coated Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Diclofenac Sodium Enteric-coated Tablets Company Product Type and Application
  8. 3.8 Global Diclofenac Sodium Enteric-coated Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diclofenac Sodium Enteric-coated Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diclofenac Sodium Enteric-coated Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diclofenac Sodium Enteric-coated Tablets Market by Type
  1. 4.1 Diclofenac Sodium Enteric-coated Tablets Type Introduction
  2. 4.1.1 25mg
  3. 4.1.2 50mg
  4. 4.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type
  5. 4.2.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type
  9. 4.3.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type (2021-2032)
5 Diclofenac Sodium Enteric-coated Tablets Market by Application
  1. 5.1 Diclofenac Sodium Enteric-coated Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application
  6. 5.2.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application
  10. 5.3.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application (2021-2032)
6 Diclofenac Sodium Enteric-coated Tablets Regional Sales and Value Analysis
  1. 6.1 Global Diclofenac Sodium Enteric-coated Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diclofenac Sodium Enteric-coated Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Diclofenac Sodium Enteric-coated Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Diclofenac Sodium Enteric-coated Tablets Sales by Region (2027-2032)
  5. 6.3 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Diclofenac Sodium Enteric-coated Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diclofenac Sodium Enteric-coated Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Country, 2025 VS 2032
7 Diclofenac Sodium Enteric-coated Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Diclofenac Sodium Enteric-coated Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diclofenac Sodium Enteric-coated Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Diclofenac Sodium Enteric-coated Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Diclofenac Sodium Enteric-coated Tablets Sales by Country (2027-2032)
  6. 7.4 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diclofenac Sodium Enteric-coated Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diclofenac Sodium Enteric-coated Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changchun Changqing Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Changchun Changqing Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Changchun Changqing Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  6. 8.1.5 Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Changchun Changhong Pharmaceutical Co., Ltd.
  8. 8.2.1 Changchun Changhong Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Changchun Changhong Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Changchun Changhong Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Changchun Changhong Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  12. 8.2.5 Changchun Changhong Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Xinxiang Changle Pharmaceutical Co., Ltd.
  14. 8.3.1 Xinxiang Changle Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Xinxiang Changle Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Xinxiang Changle Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xinxiang Changle Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  18. 8.3.5 Xinxiang Changle Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Renhetang Pharmaceutical Co., Ltd.
  20. 8.4.1 Renhetang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Renhetang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Renhetang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Renhetang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  24. 8.4.5 Renhetang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Livzon Group Livzon Pharmaceutical Factory
  26. 8.5.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  27. 8.5.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  28. 8.5.3 Livzon Group Livzon Pharmaceutical Factory Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Livzon Group Livzon Pharmaceutical Factory Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  30. 8.5.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  31. 8.6 Jiangxi Jurentang Pharmaceutical Co., Ltd.
  32. 8.6.1 Jiangxi Jurentang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jiangxi Jurentang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jiangxi Jurentang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Jurentang Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  36. 8.6.5 Jiangxi Jurentang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jilin Changheng Pharmaceutical Co., Ltd.
  38. 8.7.1 Jilin Changheng Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jilin Changheng Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jilin Changheng Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Changheng Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  42. 8.7.5 Jilin Changheng Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jilin Yinok Pharmaceutical Co., Ltd.
  44. 8.8.1 Jilin Yinok Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jilin Yinok Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jilin Yinok Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Yinok Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  48. 8.8.5 Jilin Yinok Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jilin Guowen Pharmaceutical Co., Ltd.
  50. 8.9.1 Jilin Guowen Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jilin Guowen Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jilin Guowen Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jilin Guowen Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  54. 8.9.5 Jilin Guowen Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin ASEAN Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin ASEAN Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin ASEAN Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin ASEAN Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jilin ASEAN Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  60. 8.10.5 Jilin ASEAN Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Huizhou Daya Pharmaceutical Co., Ltd.
  62. 8.11.1 Huizhou Daya Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Huizhou Daya Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Huizhou Daya Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Huizhou Daya Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  66. 8.11.5 Huizhou Daya Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Henan Baiquan Pharmaceutical Co., Ltd.
  68. 8.12.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Henan Baiquan Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Henan Baiquan Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  72. 8.12.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Henan Blueprint Pharmaceutical Co., Ltd.
  74. 8.13.1 Henan Blueprint Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Henan Blueprint Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Henan Blueprint Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Henan Blueprint Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  78. 8.13.5 Henan Blueprint Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Guangdong Rote Pharmaceutical Co., Ltd.
  80. 8.14.1 Guangdong Rote Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Guangdong Rote Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Guangdong Rote Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Guangdong Rote Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  84. 8.14.5 Guangdong Rote Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guangdong South China Pharmaceutical Group Co., Ltd.
  86. 8.15.1 Guangdong South China Pharmaceutical Group Co., Ltd. Company Information
  87. 8.15.2 Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview
  88. 8.15.3 Guangdong South China Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangdong South China Pharmaceutical Group Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  90. 8.15.5 Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments
  91. 8.16 Guangdong Bangmin Pharmaceutical Factory Co., Ltd.
  92. 8.16.1 Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Company Information
  93. 8.16.2 Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Business Overview
  94. 8.16.3 Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  96. 8.16.5 Guangdong Bangmin Pharmaceutical Factory Co., Ltd. Recent Developments
  97. 8.17 Ganmei (Guangdong) Pharmaceutical Co., Ltd.
  98. 8.17.1 Ganmei (Guangdong) Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Ganmei (Guangdong) Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Ganmei (Guangdong) Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Ganmei (Guangdong) Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  102. 8.17.5 Ganmei (Guangdong) Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Foshan Shouxin Pharmaceutical Co., Ltd.
  104. 8.18.1 Foshan Shouxin Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Foshan Shouxin Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Foshan Shouxin Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Foshan Shouxin Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  108. 8.18.5 Foshan Shouxin Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  110. 8.19.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  114. 8.19.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd.
  116. 8.20.1 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Diclofenac Sodium Enteric-coated Tablets Product Portfolio
  120. 8.20.5 Baiyunshan Tangyin Dongtai Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diclofenac Sodium Enteric-coated Tablets Value Chain Analysis
  2. 9.1.1 Diclofenac Sodium Enteric-coated Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diclofenac Sodium Enteric-coated Tablets Sales Mode & Process
  6. 9.2 Diclofenac Sodium Enteric-coated Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diclofenac Sodium Enteric-coated Tablets Distributors
  9. 9.2.3 Diclofenac Sodium Enteric-coated Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst